Annual Drug Patent Expirations for BENICAR Benicar is a drug marketed by Daiichi Sankyo and is included in two NDAs. It is available from three suppliers. BENICAR drug price trends.…
The post Patent delisted for Daiichi Sankyo drug BENICAR appeared fir…
Annual Drug Patent Expirations for ALOXI Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from three suppliers. There are thirteen patents…
The post Patent delisted for Helsinn Hlthcare drug ALOXI appeared first…
Annual Drug Patent Expirations for BENICAR+HCT Benicar Hct is a drug marketed by Daiichi Sankyo and is included in one NDA. It is available from three suppliers. BENICAR HCT drug…
The post Patent delisted for Daiichi Sankyo drug BENICAR HCT appeared fi…
Patent delisted for Daiichi Sankyo drug BENICAR HCT Read Post »
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…
The post Patent delisted for Astrazeneca Ab drug BYDUREON appeared first…
Patent delisted for Astrazeneca Ab drug BYDUREON Read Post »
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…
The post Patent delisted for Astrazeneca Ab drug BYDUREON PEN appear…
Patent delisted for Astrazeneca Ab drug BYDUREON PEN Read Post »
Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…
The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPate…
Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are five patents…
The post Patent delisted for Taiho Oncology drug LONSURF appeared first on Dr…
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fifteen…
The post Patent delisted for Boehringer Ingelheim drug TRIJARDY XR a…
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR Read Post »
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…
The post Patent delisted for Merck Sharp drug PREVYMIS appeared first on DrugP…
DEXYCU KIT (dexamethasone) Eyepoint pharms Patent: 10,022,502 Expiration: Sep 12, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dru…
Drug Patent Expirations for the Week of September 6, 2020 Read Post »